Merit Medical Systems Stock Forecast, Price & News

+0.65 (+1.04 %)
(As of 06/23/2021 12:49 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume4,858 shs
Average Volume266,141 shs
Market Capitalization$3.52 billion
P/E Ratio898.70
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive MMSI News and Ratings via Email

Sign-up to receive the latest news and ratings for Merit Medical Systems and its competitors with MarketBeat's FREE daily newsletter.

Merit Medical Systems logo

About Merit Medical Systems

Merit Medical Systems, Inc. manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, hemostasis, intervention, fluid management, electrophysiology and cardiac rhythm management, and hemodynamic monitoring to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, swab and collection systems, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, advanced over-the-wire and direct visualization delivery systems, and dilation balloons; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.54 out of 5 stars

Medical Sector

529th out of 2,105 stocks

Surgical & Medical Instruments Industry

44th out of 174 stocks

Analyst Opinion: 1.4Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Merit Medical Systems (NASDAQ:MMSI) Frequently Asked Questions

Is Merit Medical Systems a buy right now?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Merit Medical Systems in the last year. There are currently 1 hold rating and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Merit Medical Systems stock.
View analyst ratings for Merit Medical Systems
or view top-rated stocks.

What stocks does MarketBeat like better than Merit Medical Systems?

Wall Street analysts have given Merit Medical Systems a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Merit Medical Systems wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Merit Medical Systems' next earnings date?

Merit Medical Systems is scheduled to release its next quarterly earnings announcement on Wednesday, August 4th 2021.
View our earnings forecast for Merit Medical Systems

How were Merit Medical Systems' earnings last quarter?

Merit Medical Systems, Inc. (NASDAQ:MMSI) posted its quarterly earnings data on Thursday, April, 29th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.37 by $0.15. The medical instruments supplier had revenue of $248.91 million for the quarter, compared to analyst estimates of $231.06 million. Merit Medical Systems had a net margin of 0.44% and a trailing twelve-month return on equity of 10.74%.
View Merit Medical Systems' earnings history

How has Merit Medical Systems' stock price been impacted by Coronavirus (COVID-19)?

Merit Medical Systems' stock was trading at $32.88 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, MMSI shares have increased by 91.1% and is now trading at $62.85.
View which stocks have been most impacted by COVID-19

What guidance has Merit Medical Systems issued on next quarter's earnings?

Merit Medical Systems issued an update on its FY 2021 earnings guidance on Thursday, May, 6th. The company provided EPS guidance of 1.840-1.980 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.900. The company issued revenue guidance of $994 M-$1.01 billion, compared to the consensus revenue estimate of $999.65 million.

What price target have analysts set for MMSI?

8 brokerages have issued 1-year price targets for Merit Medical Systems' stock. Their forecasts range from $58.00 to $73.00. On average, they anticipate Merit Medical Systems' share price to reach $67.00 in the next year. This suggests a possible upside of 6.6% from the stock's current price.
View analysts' price targets for Merit Medical Systems
or view top-rated stocks among Wall Street analysts.

Who are Merit Medical Systems' key executives?

Merit Medical Systems' management team includes the following people:
  • Mr. Fred P. Lampropoulos, Chairman, CEO & Pres (Age 71, Pay $2.73M)
  • Mr. Raul Parra Jr., CPA, CFO & Treasurer (Age 42, Pay $862.89k)
  • Mr. Ronald A. Frost, Chief Operating Officer (Age 59, Pay $865.38k)
  • Mr. Brian G. Lloyd, Chief Legal Officer & Corp. Sec. (Age 60, Pay $796.15k)
  • Mr. Justin J. Lampropoulos, Pres of EMEA (Age 38, Pay $853.85k)
  • Mr. Jason Treft, Chief Technology Officer
  • Mr. Joseph Pierce, Chief Information Officer
  • Ms. Anne-Marie Wright, VP of Corp. Communications
  • Mr. Michel J. Voigt, Chief HR Officer (Age 48)
  • Mr. John Knorpp, Chief Regulatory Affairs Officer

What is Fred P. Lampropoulos' approval rating as Merit Medical Systems' CEO?

158 employees have rated Merit Medical Systems CEO Fred P. Lampropoulos on Fred P. Lampropoulos has an approval rating of 73% among Merit Medical Systems' employees.

Who are some of Merit Medical Systems' key competitors?

What other stocks do shareholders of Merit Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Merit Medical Systems investors own include Citigroup (C), OraSure Technologies (OSUR), LightPath Technologies (LPTH), (OSTK), EXFO (EXFO), Energy Transfer (ET), RTI Surgical (RTIX), NVIDIA (NVDA), Under Armour (UA) and Advanced Micro Devices (AMD).

What is Merit Medical Systems' stock symbol?

Merit Medical Systems trades on the NASDAQ under the ticker symbol "MMSI."

Who are Merit Medical Systems' major shareholders?

Merit Medical Systems' stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (13.98%), Starboard Value LP (6.68%), William Blair Investment Management LLC (6.21%), Conestoga Capital Advisors LLC (4.19%), Dimensional Fund Advisors LP (2.81%) and Aristotle Capital Boston LLC (2.49%). Company insiders that own Merit Medical Systems stock include A Scott Anderson, Brian G Lloyd, David Floyd, David Ming-Teh Liu, Enterprise Associates 14 New, F Ann Millner, Franklin J Miller, Fred P Lampropoulos, Joseph Wright, Michael E Stillabower, Nolan E Karras, Raul Jr Parra and Ronald Frost.
View institutional ownership trends for Merit Medical Systems

Which major investors are selling Merit Medical Systems stock?

MMSI stock was sold by a variety of institutional investors in the last quarter, including Nuance Investments LLC, Soltis Investment Advisors LLC, Starboard Value LP, Goldman Sachs Group Inc., Dimensional Fund Advisors LP, Rothschild & Co. Asset Management US Inc., Aristotle Capital Boston LLC, and Sei Investments Co.. Company insiders that have sold Merit Medical Systems company stock in the last year include A Scott Anderson, Brian G Lloyd, Fred P Lampropoulos, Joseph Wright, Raul Jr Parra, and Ronald Frost.
View insider buying and selling activity for Merit Medical Systems
or view top insider-selling stocks.

Which major investors are buying Merit Medical Systems stock?

MMSI stock was acquired by a variety of institutional investors in the last quarter, including Loomis Sayles & Co. L P, Conestoga Capital Advisors LLC, Westwood Holdings Group Inc., BlackRock Inc., Emerald Advisers LLC, Ziegler Capital Management LLC, William Blair Investment Management LLC, and Emerald Mutual Fund Advisers Trust. Company insiders that have bought Merit Medical Systems stock in the last two years include David Floyd, Enterprise Associates 14 New, Raul Jr Parra, and Ronald Frost.
View insider buying and selling activity for Merit Medical Systems
or or view top insider-buying stocks.

How do I buy shares of Merit Medical Systems?

Shares of MMSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Merit Medical Systems' stock price today?

One share of MMSI stock can currently be purchased for approximately $62.85.

How much money does Merit Medical Systems make?

Merit Medical Systems has a market capitalization of $3.52 billion and generates $963.88 million in revenue each year. The medical instruments supplier earns $-9,840,000.00 in net income (profit) each year or $1.65 on an earnings per share basis.

How many employees does Merit Medical Systems have?

Merit Medical Systems employs 5,989 workers across the globe.

What is Merit Medical Systems' official website?

The official website for Merit Medical Systems is

Where are Merit Medical Systems' headquarters?

Merit Medical Systems is headquartered at 1600 WEST MERIT PARK WAY, SOUTH JORDAN UT, 84095.

How can I contact Merit Medical Systems?

Merit Medical Systems' mailing address is 1600 WEST MERIT PARK WAY, SOUTH JORDAN UT, 84095. The medical instruments supplier can be reached via phone at 801-253-1600 or via email at [email protected]

This page was last updated on 6/23/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.